Page last updated: 2024-09-02

fingolimod and Arthritis

fingolimod has been researched along with Arthritis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balimane, P; Barrish, JC; Borowski, V; Carter, PH; Cornelius, G; Cvijic, ME; D'Arienzo, C; Dyckman, AJ; Galella, MA; Gillooly, K; Gilmore, JL; Haque, L; Levesque, PC; Li, JP; Marino, A; McIntyre, KW; Mukhopadhyay, P; Pitts, WJ; Salter-Cid, L; Shen, DR; Sheppeck, JE; Taylor, T; Tebben, AJ; Warrack, B; Watterson, SH; Xie, J; Yarde, M1
Bankala, R; Doss, HM; Kapavarapu, RK; Kulkarni, P; Kumar, JS; Mathew, JE; Medishetti, R; Mudgal, J; Pal, M; Parsa, KVL; Ramarao, EVVS; Rasool, M; Shenoy, GG; Sunke, R; Thirupataiah, B1

Other Studies

2 other study(ies) available for fingolimod and Arthritis

ArticleYear
Discovery and Structure-Activity Relationship (SAR) of a Series of Ethanolamine-Based Direct-Acting Agonists of Sphingosine-1-phosphate (S1P1).
    Journal of medicinal chemistry, 2016, 07-14, Volume: 59, Issue:13

    Topics: Animals; Arthritis; Dogs; Encephalomyelitis, Autoimmune, Experimental; Ethanolamine; Female; Haplorhini; Humans; Lymphocyte Count; Lymphocytes; Male; Mice; Mice, Inbred C57BL; Rats; Rats, Inbred Lew; Receptors, Lysosphingolipid; Structure-Activity Relationship

2016
InCl
    European journal of medicinal chemistry, 2019, Jul-15, Volume: 174

    Topics: Animals; Arthritis; Cyclic Nucleotide Phosphodiesterases, Type 4; Encephalomyelitis, Autoimmune, Experimental; Freund's Adjuvant; Indium; Indoles; Molecular Structure; Multiple Sclerosis; Oligodendrocyte-Myelin Glycoprotein; Phosphodiesterase 4 Inhibitors; Quinoxalines; Rats; Structure-Activity Relationship; Zebrafish; Zebrafish Proteins

2019